Skip to main content

Advertisement

SpringerLink
Log in

Yeast-Incorporated Gallium Attenuates Glucocorticoid-Induced Bone Loss in Rats by Inhibition of Bone Resorption

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Glucocorticoids (GC) are potent anti-inflammatory agents and widely used for the treatment of many immune-mediated and inflammatory diseases, whereas GC-induced osteoporosis (GIOP) is the most common cause of secondary osteoporosis and significantly increases the patients’ morbidity and mortality. GIOP is characterized as diminished osteogenesis and accelerated bone resorption. Yeast-incorporated gallium (YG) as an organic compound not only reduces elements-associated toxicity, but also maintains its therapeutic effect on improving bone loss or promoting fracture healing in ovariectomized female rats. The aim of this study was to examine whether YG could prevent GC-induced bone loss. Five-month-old male Sprague–Dawley rats were randomly divided into three groups (n = 6): two groups were administered dexamethasone (0.1 mg/kg/day) or vehicle (PBS) subcutaneously for 5 weeks; one other group was received dexamethasone subcutaneously and YG (120 μg/kg/day) orally. Trabecular bone microarchitectural parameters, bone mineral density (BMD), bone strength, body weight, and serum biochemical markers of bone resorption and formation were examined. Compared to the GC alone group, treatment with YG not only prevented microarchitectural deterioration of trabecular bone volume relative to tissue volume, trabecular number, and trabecular separation, but also significantly improved BMD, mechanical strength, and body weight in GC-treated rats. Moreover, YG decreased tartrate-resistant acid phosphatase 5b level but failed to change alkaline phosphatase level in GC-treated rats. This is the first study to show that YG prominently attenuates bone loss and microarchitectural deterioration and inhibits the increased bone resorption in GIOP. It implies that YG might be an alternative therapy for prevention of GC-induced bone loss in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 17:144–149

    Article  PubMed  CAS  Google Scholar 

  2. Weinstein RS (2011) Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 365:62–70

    Article  PubMed  CAS  Google Scholar 

  3. Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325

    Article  PubMed  CAS  Google Scholar 

  4. Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319–1328

    Article  PubMed  CAS  Google Scholar 

  5. Bockman RS, Boskey AL, Blumenthal NC, Alcock NW, Warrell RP Jr (1986) Gallium increases bone calcium and crystallite perfection of hydroxyapatite. Calcif Tissue Int 39:376–381

    Article  PubMed  CAS  Google Scholar 

  6. Bockman RS, Repo MA, Warrell RP Jr et al (1990) Distribution of trace levels of therapeutic gallium in bone as mapped by synchrotron X-ray microscopy. Proc Natl Acad Sci USA 87:4149–4153

    Article  PubMed  CAS  Google Scholar 

  7. Bockman R (2003) The effects of gallium nitrate on bone resorption. Semin Oncol 30:5–12

    Article  PubMed  CAS  Google Scholar 

  8. Korbas M, Rokita E, Meyer-Klaucke W, Ryczek J (2004) Bone tissue incorporates in vitro gallium with a local structure similar to gallium-doped brushite. J Biol Inorg Chem 9:67–76

    Article  PubMed  CAS  Google Scholar 

  9. Verron E, Bouler JM, Scimeca JC (2012) Gallium as a potential candidate for treatment of osteoporosis. Drug Discov Today 17:1127–1132

    Article  PubMed  CAS  Google Scholar 

  10. Warrell RP Jr, Bockman RS, Coonley CJ, Isaacs M, Staszewski H (1984) Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia. J Clin Invest 73:1487–1490

    Article  PubMed  CAS  Google Scholar 

  11. Warrell RP Jr, Skelos A, Alcock NW, Bockman RS (1986) Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose–response analysis. Cancer Res 46:4208–4212

    PubMed  Google Scholar 

  12. Warrell RP Jr, Israel R, Frisone M, Snyder T, Gaynor JJ, Bockman RS (1988) Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison with calcitonin. Ann Intern Med 108:669–674

    Article  PubMed  Google Scholar 

  13. Warrell RP Jr (1997) Gallium nitrate for the treatment of bone metastases. Cancer 80:1680–1685

    Article  PubMed  CAS  Google Scholar 

  14. Warrell RP Jr, Bosco B, Weinerman S, Levine B, Lane J, Bockman RS (1990) Gallium nitrate for advanced Paget disease of bone: effectiveness and dose–response analysis. Ann Intern Med 113:847–851

    Article  PubMed  Google Scholar 

  15. Niesvizky R (2003) Gallium nitrate in multiple myeloma: prolonged survival in a cohort of patients with advanced-stage disease. Semin Oncol 30:20–24

    Article  PubMed  CAS  Google Scholar 

  16. Li C, Jiang Z, Liu X (2010) Biochemical mechanism of gallium on prevention of fatal cage-layer osteoporosis. Biol Trace Elem Res 134:195–202

    Article  PubMed  CAS  Google Scholar 

  17. Chen X, Wang C (2010) Activity of gallium on prevention of fatal cage-layer osteoporosis. Biol Trace Elem Res 132:129–135

    Article  Google Scholar 

  18. Foster BJ, Clagett-Carr K, Hoth D, Leyland-Jones B (1986) Gallium nitrate: the second metal with clinical activity. Cancer Treat Rep 70:1311–1319

    PubMed  CAS  Google Scholar 

  19. Liu J, Zhang B, He X, Zhang P, Chai Z (2001) Selection of a high-biomass, chromium-rich yeast strain and optimization of cultivation conditions. J Ind Microbiol Biotechnol 27:195–198

    Article  PubMed  CAS  Google Scholar 

  20. Han C, Yuan J, Wang Y, Li L (2006) Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium. J Trace Elem Med Biol 20:191–196

    Article  PubMed  CAS  Google Scholar 

  21. Han C, Cui B, Wang Y (2008) Vanadium uptake by biomass of Coprinus comatus and their effect on hyperglycemic mice. Biol Trace Elem Res 124:35–39

    Article  PubMed  CAS  Google Scholar 

  22. Ma Z, Fu Q (2010) Therapeutic effect of organic gallium on ovariectomized osteopenic rats by decreased serum minerals and increased bone mineral content. Biol Trace Elem Res 133:342–349

    Article  PubMed  CAS  Google Scholar 

  23. Ma Z, Fu Q (2010) Comparison of the therapeutic effects of yeast-incorporated gallium with those of inorganic gallium on ovariectomized osteopenic rats. Biol Trace Elem Res 134:280–287

    Article  PubMed  CAS  Google Scholar 

  24. Pei Y, Fu Q (2011) Yeast-incorporated gallium promotes fracture healing by increasing callus bony area and improving trabecular microstructure on ovariectomized osteopenic rats. Biol Trace Elem Res 141:207–215

    Article  PubMed  CAS  Google Scholar 

  25. Ko JY, Wu RW, Kuo SJ et al (2012) Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis. Arthritis Rheum 64:1204–1214

    Article  PubMed  CAS  Google Scholar 

  26. Jing D, Cai J, Shen G et al (2011) The preventive effects of pulsed electromagnetic fields on diabetic bone loss in streptozotocin-treated rats. Osteoporos Int 22:1885–1895

    Article  PubMed  CAS  Google Scholar 

  27. Dempster DW (1989) Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 4:137–141

    Article  PubMed  CAS  Google Scholar 

  28. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest 102:274–282

    Article  PubMed  CAS  Google Scholar 

  29. Cui L, Li T, Liu Y et al (2012) Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis. PLoS One 7:e34647

    Article  PubMed  CAS  Google Scholar 

  30. Thiele S, Ziegler N, Tsourdi E et al (2012) Selective glucocorticoid receptor modulation maintains bone mineral density in mice. J Bone Miner Res 27:2242–2250

    Article  PubMed  CAS  Google Scholar 

  31. Hofbauer LC, Zeitz U, Schoppet M et al (2009) Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum 60:1427–1437

    Article  PubMed  Google Scholar 

  32. Karsenty G (2003) The complexities of skeletal biology. Nature 423:316–318

    Article  PubMed  CAS  Google Scholar 

  33. Verron E, Masson M, Khoshniat S et al (2010) Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts. Br J Pharmacol 159:1681–1692

    Article  PubMed  CAS  Google Scholar 

  34. Verron E, Loubat A, Carle GF et al (2011) Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes. Biochem Pharmacol 83:671–679

    Article  PubMed  Google Scholar 

  35. Jenis LG, Waud CE, Stein GS, Lian JB, Baran DT (1993) Effect of gallium nitrate in vitro and in normal rats. J Cell Biochem 52:330–336

    Article  PubMed  CAS  Google Scholar 

  36. Merryman JI, Capen CC, Rosol TJ (1994) Effects of gallium nitrate in nude mice bearing a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy. J Bone Miner Res 9:725–732

    Article  PubMed  CAS  Google Scholar 

  37. Donnelly R, Bockman R, DiCarlo E, Betts F, Boskey A (1993) The effect of gallium nitrate on healing of vitamin D- and phosphate-deficient rickets in the immature rat. Calcif Tissue Int 53:400–410

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study is supported by the Nature Science Foundation (81070688) of China.

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, 110004, People’s Republic of China

    Zhaozhou Ren, Liqing Yang, Feng Xue, Da Liu, Long Zhou, Jing Zhang & Qin Fu

  2. Department of Vascular and Endocrine Surgery, Xijing Hospital of Fourth Military Medical University, Xi’an, Shaanxi, People’s Republic of China

    Qingjie Meng

  3. Department of Burns and Cutaneous Surgery, Xijing Hospital of Fourth Military Medical University, Xi’an, Shaanxi, People’s Republic of China

    Kejia Wang

  4. Department of Clinical Nutrition, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China

    Xian Wu

  5. Department of Epidemiology, School of Public Health, China Medical University, Shenyang, Liaoning, People’s Republic of China

    Chao Ji

  6. Key Laboratory of Health Ministry for Congenital Malformations, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China

    Teng Jiang

Authors
  1. Zhaozhou Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liqing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Feng Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qingjie Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kejia Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xian Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chao Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Teng Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Da Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Long Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Qin Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qin Fu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ren, Z., Yang, L., Xue, F. et al. Yeast-Incorporated Gallium Attenuates Glucocorticoid-Induced Bone Loss in Rats by Inhibition of Bone Resorption. Biol Trace Elem Res 152, 396–402 (2013). https://doi.org/10.1007/s12011-013-9634-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-013-9634-7

Keywords

Search

Navigation